David Baxley Spetzler, President at Caris Life Sciences, Inc. (CAI), sold 597,212 shares at $24.76 ($14.8M) on 2026-09-03, disclosed to the SEC on 2026-09-04.
Open-market sale of $14.8M CAI by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.76 | 393,100 | $9.7M | 65.6% |
| 2 | $25.32 | 84,900 | $2.1M | 14.5% |
| 3 | $24.76 | 119,212 | $3.0M | 19.9% |
| Total | $24.84 avg | 597,212 | $14.8M | 100% |